37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Combined hormonal contraception might worsen migraine in sensitive women, especially during the free-hormone interval, and raise concerns about the vascular risk. The characteristics of a contraceptive pill containing estradiol valerate/dienogest (E2V/DNG) might be of potential benefit in women with menstrually related migraine (MRM) who choose to use oral contraception for birth control.

          Related collections

          Author and article information

          Journal
          Contraception
          Contraception
          1879-0518
          0010-7824
          Sep 2013
          : 88
          : 3
          Affiliations
          [1 ] Department Obstetric and Gynecology, University of Pavia, Italy. renappi@tin.it
          Article
          S0010-7824(13)00045-0
          10.1016/j.contraception.2013.02.001
          23453784
          88bbb9d5-2256-42eb-824f-72e28ffe8a29
          Copyright © 2013 Elsevier Inc. All rights reserved.
          History

          Bleeding,Dienogest,Dysmenorrhea,Estradiol valerate,Hormonally associated headaches,Migraine without aura

          Comments

          Comment on this article